Search
SOLACI Congress
HomeFileStructural heart disease

Structural heart disease

View Category

Other

ESC 2024 | STOP-or-NOT Trial: Optimal Management of Renin-Angiotensin System Inhibition Before Non-Cardiac Surgery

Researchers conducted a multicenter, randomized study to assess the continuation of renin-angiotensin system inhibition (RASI) before major...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

SAFE-Vein: Percutaneous Closure Devices in Complex Venous Accesses

For certain structural interventions and procedures in the field of interventional electrophysiology, complex venous access (CVA) using...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap

TAVR has been shown beneficial but one of the current challenges especially in low risk populations is...
solaci -
Learn More
Structural heart disease

Do Leadless Pacemakers After TAVR Offer Benefits?

The need for pacemaker after transcatheter aortic valve replacement (TAVR) remains slightly higher than with surgery, especially...
Dr. Carlos Fava -
Learn More
Structural heart disease

When to Perform Non-Cardiac Surgery After TAVR

Transcatheter aortic valve replacement (TAVR) is becoming increasingly common, not only in high-risk or inoperable patients but...
Dr. Carlos Fava -
Learn More
Left Atrial Apendix Closure

Left Atrial Appendage Occlusion and Early Bleeding

Percutaneous left atrial appendage occlusion (LAAO) is presented as an alternative to chronic oral anticoagulation in patients...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Tricuspid Edge-to-Edge Repair: One-Year Evolution

Tricuspid Edge-to-Edge Repair has emerged as a promising alternative to surgical repair. Different studies have shown it...
Dr. Carlos Fava -
Learn More
Structural heart disease

DIRECT TAVI: Is Predilation Important for Women?

Predilation was used in the early stages of TAVR to facilitate device advancing. However, the increasing operator...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

Dr. Juan Manuel Pérez - 0
This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy